HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.

AuthorsShutaro Nakaaki, Yoshie Murata, Toshi A Furukawa
JournalPsychiatry and clinical neurosciences (Psychiatry Clin Neurosci) Vol. 62 Issue 3 Pg. 370 (Jun 2008) ISSN: 1440-1819 [Electronic] Australia
PMID18588607 (Publication Type: Letter)
Chemical References
  • Antidepressive Agents, Second-Generation
  • Antipsychotic Agents
  • Benzodiazepines
  • Paroxetine
  • Olanzapine
Topics
  • Adult
  • Antidepressive Agents, Second-Generation (administration & dosage)
  • Antipsychotic Agents (administration & dosage)
  • Benzodiazepines (adverse effects)
  • Body Image
  • Delusions (drug therapy, psychology)
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • Humans
  • Obsessive-Compulsive Disorder (drug therapy, psychology)
  • Olanzapine
  • Paroxetine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: